Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Comparative effects of semaglutide tirzepatide and retatrutide on renal fibrosis in UUO and aged mice
iScience, 2026;29(9):117174
Do Patients Receiving GLP-1 Receptor Agonists for Weight Loss Require Structured Dietetic Care? Lessons from Metabolic and Bariatric Surgery (MBS) Pathways
Nutrients, 2026;18(16)
The liver-gut-brain axis in metabolic dysfunction-associated steatotic liver disease: bidirectional communication, clinical implications, and future perspectives
Frontiers in endocrinology, 2026;17:1911290
The menopause-obesity axis in MASH progression: from estrogen decline to liver fibrosis
Frontiers in gastroenterology (Lausanne, Switzerland), 2026;5:1889458
Comparative Efficacy and Safety of Tirzepatide Versus Semaglutide for Obesity: A Systematic Review
Cureus, 2026;18(8):e114454
GLP-1 receptor agonists, metabolic syndrome, and Alzheimer’s disease: Lessons and opportunities from the EVOKE trials
Journal of neuroendocrinology;38(8):e70246
Reframing GLP-1 Therapies as Cardiometabolic Health Drugs: Beyond the Race to Weight Loss
Journal of the American College of Cardiology;88(6):649-651
Burden and Risk of Depression in Patients Receiving Semaglutide: A Systematic Review and Meta-Analysis
Clinical obesity;16(5):e70105
Association of Glucagon-Like Peptide-1 Receptor Analogues and Laryngeal Symptoms in Obese Adults
The Laryngoscope, 2026
From Pathobiology to Prescribing in Obesity-Driven HFpEF: A Systematic Review and Practical Therapeutic Framework
Current problems in cardiology, 2026;:103423
Beyond Weight Loss: Tirzepatide as a Metabolic Disease-Modifying Strategy for Metabolic Dysfunction-Associated Steatohepatitis: A Narrative Review
Health science reports, 2026;9(8):e73044
Semaglutide Attenuates Type 2 Diabetes-Induced Neurotoxicity by Modulating Neuroinflammation, Oxidative Stress, and Neuroapoptosis
Life (Basel, Switzerland), 2026;16(8)
GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide)/GLP-1 Receptor Agonists for Antipsychotic-Induced Weight Gain: A Narrative Review
Cureus, 2026;18(8):e114435
Diabetes, Adiposity, and Functional Phenotypes in HFpEF: A Systematic Review of Recent Treatment-Response Evidence
Cureus, 2026;18(8):e114404
Liver Fat Changes in Patients With Type 2 Diabetes by Presence of Genetic Hepatic Steatosis: A Post Hoc Analysis of SURPASS-3 MRI
Liver international : official journal of the International Association for the Study of the Liver;46(9):e70837
Peptide Supplements and Their Therapeutic Applications in Sports Medicine
The American journal of sports medicine, 2026;:3635465261464420
Simplified definition and imaging-based stratification of at-risk MASH using magnetic resonance elastography
Hepatology communications, 2026;10(9)
Correction: Cost-Effectiveness of Endoscopic Bariatric Therapies Compared with Laparoscopic Sleeve Gastrectomy and Semaglutide
Obesity surgery, 2026
Design, synthesis, and stability evaluation of semaglutide-derived lactam-stapled peptide scaffolds for GLP-1R targeting
Journal of enzyme inhibition and medicinal chemistry, 2026;41(1):2714331
MAFLD/MASLD: Past, Present, and Future
Journal of gastroenterology and hepatology, 2026